Gunther Birznieks

Senior Vice President Business Development at Vanda Pharmaceuticals Inc.

Gunther Birznieks

Gunther Birznieks

Senior Vice President Business Development at Vanda Pharmaceuticals Inc.

Biography

Gunther Birznieks is Vanda's Senior Vice President, Business Development. Prior to his current role, Gunther Birznieks held a number of positions at Vanda Pharmaceuticals including as Clinical Program Head of the tasimelteon and VSF-173 programs, Head of Informatics and in Singapore as Head of Operations. Mr. Birznieks previously spent the majority of his career in the areas of healthcare and biomedical informatics including bioinformatics support for microarray and genotyping projects with the Human Genome Project at NHGRI.

Prior to joining to Vanda, Gunther Birznieks founded Extropia Pte Ltd, a Singaporean company which specialized in business and investment banking applications. Gunther Birznieks has published four books on computer technologies as well as numerous articles and talks on information security, programming, and software development life cycle. He holds a B. A. in Psychology and M. S. in Computer Science from Johns Hopkins University.

Overview
Career Highlights

Extropia Pte Ltd.

RelSci Relationships

34

Birthday

1969

Age

49

Relationships
RelSci Relationships are individuals Gunther Birznieks likely has professional access to. A relationship does not necessarily indicate a personal connection.

President, Chief Executive Officer & Director at Genocea Biosciences, Inc.

Relationship likelihood: Average

Partner at Care Capital LLC

Relationship likelihood: Average

Chief Financial Officer, Secretary & Treasurer at Vanda Pharmaceuticals Inc.

Relationship likelihood: Average

President & Chief Executive Officer at Vanda Pharmaceuticals Inc.

Relationship likelihood: Average

Vice President of Manufacturing at Vanda Pharmaceuticals Inc.

Relationship likelihood: Average

Co-Founder & Head, Business Development at Vanda Pharmaceuticals Inc.

Relationship likelihood: Average

Senior Director Program Director at Vanda Pharmaceuticals Inc.

Relationship likelihood: Average

Former Chief Financial Officer, Secretary, Treasurer & CAO at Vanda Pharmaceuticals Inc.

Relationship likelihood: Average

Former Senior Vice President & Chief Medical Officer at Supernus Pharmaceuticals, Inc.

Relationship likelihood: Average

Chief Executive Officer, Chief Financial Officer, Secretary & Treasurer at Synthetic Biologics, Inc.

Relationship likelihood: Average

Paths to Gunther Birznieks
Potential Connections via
Relationship Science
You
Gunther Birznieks
Senior Vice President Business Development at Vanda Pharmaceuticals Inc.
Education
B. A. in Psychology

The Johns Hopkins University opened in 1876, with the inauguration of its first president, Daniel Coit Gilman. "What are we aiming at?" Gilman asked in his installation address. "The encouragement of research ... and the advancement of individual scholars, who by their excellence will advance the sciences they pursue, and the society where they dwell." The mission laid out by Gilman remains the university's mission today, summed up in a simple but powerful restatement of Gilman's own words: "Knowledge for the world." What Gilman created was a research university, dedicated to advancing both students' knowledge and the state of human knowledge through research and scholarship. Gilman believed that teaching and research are interdependent, that success in one depends on success in the other. A modern university, he believed, must do both well. The realization of Gilman's philosophy at Johns Hopkins, and at other institutions that later attracted Johns Hopkins-trained scholars, revolutionized higher education in America, leading to the research university system as it exists today. After more than 130 years, Johns Hopkins remains a world leader in both teaching and research. Eminent professors mentor top students in the arts and music, the humanities, the social and natural sciences, engineering, international studies, education, business and the health professions. Those same faculty members, and their research colleagues at the university's Applied Physics Laboratory, have each year since 1979 won Johns Hopkins more federal research and development funding than any other university. The university has nine academic divisions and campuses throughout the Baltimore-Washington area. The Krieger School of Arts and Sciences, the Whiting School of Engineering, the School of Education and the Carey Business School are based at the Homewood campus in northern Baltimore. The schools of Medicine, Public Health, and Nursing share a campus in east Baltimore with The Johns Hopkins Hospital. The Peabody Institute, a leading professional school of music, is located on Mount Vernon Place in downtown Baltimore. The Paul H. Nitze School of Advanced International Studies is located in Washington's Dupont Circle area. The Applied Physics Laboratory is a division of the university co-equal to the nine schools, but with a non-academic, research-based mission. APL, located between Baltimore and Washington, supports national security and also pursues space science, exploration of the Solar System and other civilian research and development. Johns Hopkins also has a campus near Rockville in Montgomery County, Md., and has academic facilities in Nanjing, China, and in Bologna, Italy. It maintains a network of continuing education facilities throughout the Baltimore-Washington region, including centers in downtown Baltimore, in downtown Washington and in Columbia. When considered in partnership with its sister institution, the Johns Hopkins Hospital and Health System, the university is Maryland's largest employer and contributes more than $10 billion a year to the state's economy

Career History
Senior Vice President Business Development
2003 - Current

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Founder
Prior
Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations

Gunther Birznieks is affiliated with Vanda Pharmaceuticals Inc., Extropia Pte Ltd.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Gunther Birznieks. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Gunther Birznieks's profile does not indicate a business or promotional relationship of any kind between RelSci and Gunther Birznieks.